MTOR and Sepsis: In vitro studies have demonstrated that administering IL-7 to T cells from these patients can ameliorate certain indicators of metabolic failure via the activation of mTOR.73The observed immunometabolic dysregulation in sepsis contributes significantly to overall complexity of the disease and is posited to be a key determinant in the overarching immunosuppressive state.